Local Probiotic Therapy for Vaginal Candida albicans Infections

Probiotics and Antimicrobial Proteins

Volumn 7, Issue 1, 2015, Pages 38-44

  Kovachev, Stefan Miladinov ^a,c   Vatcheva Dobrevska, Rossitza Stefanova ^b  

^a MILITARY MEDICAL ACADEMY   (Bulgaria)

^b UNIVERSITY HOSPITAL 'QUEEN GIOVANNA'   (Bulgaria)

^c NONE   (Bulgaria)

Author keywords

Azoles; Lactobacilli; Probiotic; Vaginal Candida albicans

Indexed keywords

FENTICONAZOLE; FLUCONAZOLE; PROBIOTIC AGENT; ANTIFUNGAL AGENT;

ADULT; ARTICLE; FEMALE; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MICROBIOLOGICAL PARAMETERS; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SEXUAL ABSTINENCE; SINGLE DRUG DOSE; STREPTOCOCCUS THERMOPHILUS; VAGINA CANDIDIASIS; VAGINA PH; ADOLESCENT; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CONTROLLED STUDY; DRUG EFFECTS; FOLLOW UP; MICROBIOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PH; VAGINA; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; FEMALE; FLUCONAZOLE; FOLLOW-UP STUDIES; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS RHAMNOSUS; MIDDLE AGED; PROBIOTICS; STREPTOCOCCUS THERMOPHILUS; VAGINA; YOUNG ADULT;

EID: 84925539932     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-014-9176-0     Document Type: Article

References (29)

1. Hogan DA, Kolter R (2006) Bacterial-fungal interactions in the female reproductive tract. Molecular principles of fungal pathogenesis. ASM Press, Washington, DC, pp 266–267
2. Monif GRG, Baker DA (2004) Candida albicans. Infectious diseases in obstetrics and gynecology, 5th edn. The Parthenon Publishing Group, Nashville, pp 405–421
3. Mitchell TG (2010) Medical mycology. Jawetz, Melnick and Adelberg’s medical microbiology, 25th edn. The McGraw-Hill Companies Inc., New York, pp 623–661
4. Vermitsky JP, Self MJ, Chadwick SG, Trama JP, Adelson ME, Mordechai E, Gygax SE (2008) Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection. J Clin Microbiol 46:1501–1503
5. Hidalgo JA, Vazquez JA (2008) Candidiasis. http://emedicine.medscape.com/article/213853-overview. Accessed 16 Oct 2014
6. Kovachev S, Nacheva A, Vacheva-Dobrevska R, Vasilev N (2009) Combined single-day treatment in acute vulvovaginal candidosis. Akush Ginekol (Sofiia) 48:18–23
7. Fan SR, Liu XP (2011) In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. Mycoses 54:501–505
8. Ge SH, Wan Z, Li J, Xu J, Li RY, Bai FY (2010) Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China. Antimicrob Agents Chemother 54:3126–3131
9. Richter SS, Galask RP, Messer SA et al (2005) Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of reccurrent cases. J Clin Microbiol 43:2155–2162
10. Martinez RCR, Franceschini SA, Patta MC et al (2009) Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol 48:269–274
11. Reid G, Beuerman D, Heinemann C, Bruce AW (2001) Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 32:37–41
12. CDC and Prevention Treatment Guidelines (2010). MMWR. 59: No. RR-12
13. Mazneĭkova V (2003) Vaginal candidiasis–treatment protocols using miconazole and fluconazole. Akush Ginekol (Sofiia) 42(Suppl 2):30–34
14. Sobel JD, Zervos M, Reed BD et al (2003) Fluconazole susceptibility of vaginal isolates obtained from women with Candida vaginitis: clinical implications. Antimicrob Agents Chemother 47:34–38
15. Köhler GA, Assefa S, Reid G (2012) Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol 2012:636474
16. Osset J, Garcia E, Bartolome RM et al (2001) Role of Lactobacillus as protector against vaginal candidiasis. Med Clin 117:285–288
17. Strus M, Kuchaska A, Kukla G, Brzychczy-Wloch M, Maresz K, Heczko PB (2005) The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 13:69–75
18. Martinez RC, Senev SL, Summers KL, Nomizo A, De Martinis EC, Reid G (2009) Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation. Microbiol Immunol 53:487–495
19. Mestecky J, Russell MW (2000) Induction of mucosal immune responses in the human genital tract. FEMS Immunol Medical Microbiol 27:351–355
20. Witkin SS (2004) Immunological defence mechanisms in the female genital tract. Infectious diseases in obstetrics and gynecology, 5th edn. The Parthenon Publishing Group, Nashville, pp 8–12
21. Wagner RD, Johnson SJ (2012) Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 19:58
22. Yang VW, Clausen CA (2005) Determining the suitability of Lactobacilli antifungal metabolites for inhibiting mould growth. World J Microb Biotech 21:977–981
23. Kaewsrichan J, Peeyananjarassri K, Kougprasertkit J (2006) Selection and identification of anaerobic lactobacilli producing inhibitory components against vaginal pathogens. FEMS Immunol Med Microbiol 48:75–83
24. Okkers DJ, Dicks LM, Silvester M et al (1999) Characterization of pentocin TV35b, a bacteriocin like peptide isolated from Lactobacillus pentosus with fungistatic effect against C. albicans. J Appl Microbiol 87:726–734
25. Strus M, Brzychczy-Wloch M, Gosiewski T, Kochan P, Heczko PB (2006) The in vitro effect of hydrogen peroxide on vaginal microbial communities. FEMS Immunol Med Microbiol 48:56–63
26. Hilton E, Rindos P, Isenberg H (1995) Lactobacillus GG vaginal suppositories and vaginitis. J Clin Microbiol 33:1433
27. Pirotta M, Gunn J, Chondros P et al (2004) Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomized controlled trial. BMJ 329:548–552
28. Vicariotto F, Del Piano M, Mogna L, Mogna G (2012) Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study. J Clin Gastroenterol 46(Suppl):S73–S80
29. Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N (2004) Comparative study of itraconazole and fluconazole therapy in vaginal candidosis. Akush Ginekol (Sofiia) 43:20–23